• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Diabetes mellitus and lipoproteins].

作者信息

Somogyi A

机构信息

II. Belklinika, Semmelweis Orvostudományi Egyetem Budapest.

出版信息

Orv Hetil. 1993 Oct 24;134(43):2371-7.

PMID:8233456
Abstract

The leading cause of death of diabetic patients is coronary heart disease developing on the basis of accelerated arteriosclerosis. Lipoprotein disorders commonly accompanying diabetes mellitus (DM) promote this process and their joint presence represent cumulated risks for patients. The present review summarizes the various disorders accompanying the two types of DM. In case of insulin-treated, type I, well adjusted DM without signs of primary disturbances of lipid metabolism, quantitative lipid alterations cannot be found. In poorly treated DM with insufficient insulin levels the accumulation of triglyceride particles is due to diminished lipoprotein lipase activity. The main consequence is hyperchylomicronaemia but all three lipoprotein classes are affected. The most characteristic lipid abnormalities in non-insulin-dependent (type II) DM are hypertriglyceridaemia, increased VLDL cholesterol concentration and decreased HDL levels, which frequently remain unchanged even upon the proper treatment of glucose metabolism. The alterations are related to increased free fatty acid levels and decreased glucose uptake resulting from elevated insulin levels. In about one-fourth of cases, primary hyperlipaemia is also present. The treatment of primary and secondary lipid disorders accompanying DM by diet and drugs is of the most uttermost importance.

摘要

相似文献

1
[Diabetes mellitus and lipoproteins].
Orv Hetil. 1993 Oct 24;134(43):2371-7.
2
[Disorders of lipid metabolism in diabetes mellitus].
Wien Med Wochenschr Suppl. 1989;105:9-17.
3
Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.糖尿病中的血脂异常。主要脂蛋白异常及其对动脉粥样硬化发生发展影响的综述。
Diabetes Metab. 1999 Jun;25 Suppl 3:32-40.
4
Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.2型糖尿病患者在口服降糖药或胰岛素治疗期间的血脂谱和脂蛋白a水平比较。
Saudi Med J. 2006 Feb;27(2):174-80.
5
Dyslipoproteinemia and diabetes.
Endocrinol Metab Clin North Am. 1990 Jun;19(2):361-80.
6
Management of hypercholesterolaemia in the patient with diabetes.糖尿病患者高胆固醇血症的管理
Int J Clin Pract Suppl. 2002 Jul(130):27-32.
7
Management of hyperlipidemia in diabetes mellitus.糖尿病患者高脂血症的管理
Endocrinol Metab Clin North Am. 1992 Jun;21(2):395-414.
8
Hyperlipidemia in children with type 2 diabetes mellitus.2型糖尿病患儿的高脂血症
J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:505-7.
9
Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.了解和治疗与非胰岛素依赖型糖尿病及高血压相关的血脂异常。
Pharmacotherapy. 1993 Jul-Aug;13(4):340-52.
10
[Changes of lipoproteins during insulin therapy in diabetes mellitus type 1].[1型糖尿病胰岛素治疗期间脂蛋白的变化]
Med Pregl. 2009;62 Suppl 3:66-9.

引用本文的文献

1
Amelioration of diabetic dyslipidemia by macrocyclic binuclear oxovanadium complex on streptozotocin induced diabetic rats.大环双核氧钒配合物对链脲佐菌素诱导的糖尿病大鼠糖尿病血脂异常的改善作用
Mol Cell Biochem. 2005 Apr;272(1-2):157-64. doi: 10.1007/s11010-005-6988-y.